TRCT
BRAI

Tower Research Capital (TRC)’s Braiin Ltd BRAI Stock Holding History

Tower Research Capital (TRC)’s Portfolio BRAI Stock Details BRAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3
Closed -$21 – 5837
2026
Q1 		$21 Buy
+3
New +$23 ﹤0.01% 5061

Other funds holding BRAI

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tower Research Capital (TRC)'s BRAI Position: Q2 2026 in Review

Tower Research Capital (TRC) sold out of Braiin Ltd (BRAI) in Q2 2026, closing a stake of 3 shares — an estimated $21 sold.

Tower Research Capital (TRC) first reported a position in BRAI in Q1 2026 and held it in 1 quarter. The position peaked at $21 in Q1 2026. 7 funds tracked by Wall St. Rank hold BRAI as of Q2 2026.

  • Tower Research Capital (TRC) reported no remaining Braiin Ltd position as of Q2 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 3 Braiin Ltd shares in Q2 2026, an estimated $21.
  • Tower Research Capital (TRC) first reported a position in Braiin Ltd in Q1 2026 and held it in 1 quarter.
  • Tower Research Capital (TRC)'s Braiin Ltd position peaked at $21 in Q1 2026.
  • 7 funds tracked by Wall St. Rank held Braiin Ltd as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.